Fumi-ichiro Yamamoto

Title: Fumi-ichiro Yamamoto: Innovator in Histo-Blood Group Research

Introduction

Fumi-ichiro Yamamoto is a notable inventor based in King County, WA (US). He has made significant contributions to the field of genetics, particularly in the study of histo-blood groups. With a total of 2 patents, his work has advanced the understanding of blood group identification and its implications.

Latest Patents

Yamamoto's latest patents focus on ABO genotyping. The genes defining the ABO histo-blood groups are disclosed in these patents. Methods for identifying histo-blood group ABO status are provided, which include the use of DNA probes or size separation of DNA fragments unique to a blood group status. Additionally, the patents disclose DNA constructs, recombinant methods for providing histo-blood glycosyltransferases, methods for tumor suppression, purified histo-blood group glycosyltransferases, and antibodies produced therefrom that bind to protein epitopes. Another significant patent involves purified histo-blood group A glycosyltransferase and antibodies related to it, further enhancing the methods for identifying blood group status.

Career Highlights

Fumi-ichiro Yamamoto is associated with The Biomembrane Institute, where he continues to conduct research and develop innovative solutions in his field. His work has been instrumental in advancing the understanding of blood group genetics and its applications in medicine.

Collaborations

Yamamoto has collaborated with notable colleagues, including Sen-itiroh Hakomori and Thayer White, who have contributed to his research endeavors.

Conclusion

Fumi-ichiro Yamamoto's contributions to the field of histo-blood group research have been significant. His innovative patents and collaborations reflect his commitment to advancing genetic research and its applications in healthcare.